Rochester,NY 7/11/2009 2:34:01 AM
Afternoon Stock Report - DSCO - Get Ready for a 25% Drop - Sourced WhisperFromWallStreet.com
Discovery Laboratories Inc.
Afternoon Stock Report - DSCO - Get Ready for a 25% Drop - Sourced WhisperFromWallStreet.com
Discovery Laboratories Inc. DSCO
Back in July of 1995, this friend -- let's call him Charlie -- bought Microsoft at what turned out to be the highest price it would reach that year. The stock was down 15% in no time, and Charlie was worried. He was smart enough to know the market is the best wealth-creating machine available to us regular folks, but he felt about stocks the way Elizabeth Taylor felt about husbands. He liked them well enough, but he tended to give up when things got a little rocky.
In a matter of weeks his paper loss was approaching 25%, and he couldn't stand it anymore. He bailed out.
Needless to say, the next few years were even rougher on Charlie as he watched Mr. Softy march steadily higher. It achieved 10-bagger status at the height of the bull market in 2000, but even today it has returned more than 220% from when he sold.
Last Trade: 0.4013
Day's Range: 0.40 - 0.42
52wk Range: 0.40 - 2.40
Volume: 1,859,434
ABOUT - Discovery Laboratories Inc.
Discovery Laboratories, Inc., a biotechnology company, engages in developing surfactant replacement therapies (SRT) to treat respiratory disorders and diseases. The company's proprietary technology, KL4 Surfactant Technology, produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant. Its products include Surfaxin, a synthetic, peptide-containing surfactant for use in pediatric medicine; Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS) in premature infants; and Aerosurf, which is a KL4 Surfactant in aerosolized form to treat premature infants at risk for RDS. Discovery Laboratories also focuses on the development of Surfaxin to address bronchopulmonary dysplasia in premature infants, acute respiratory failure in children, cystic fibrosis, acute lung injury, and other diseases associated with the inflammation of the lung, such as asthma and chronic obstructive pulmonary disease.
---
During 2009 we have sent 40+ alerts with an average gain of over 80%. Below are a few alerts sent only to our whisperfromwallstreet.com members.
SPNG 1800%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up now to receive free stock alerts
---
Please Read Our Disclaimer at http://whisperfromwallstreet.com/disclaimer.php
